Manual of Surgical Pathology

Manual of Surgical Pathology

Volumn , Issue , 2010, Pages

  Lester, Susan ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85013689360     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/C2009-0-38878-9     Document Type: Book

References (338)

1. Nakhleh R.E., Zarbo R.J. Surgical pathology specimen identification and accessioning. A College of American Pathologists Q-Probes study of 1,004,115 cases from 417 institutions. Arch Pathol Lab Med 1996, 120:227-233.
2. Makary M.A., et al. Surgical specimen identification errors: a new measure of quality in surgical care. Surgery 2007, 141:450-455.
3. Bull A.D., Cross S.S., James D.S., Silcocks P.B. Do pathologists have extrasensory perception?. BMJ 1991, 303:1604-1605.
4. Wiley E.L., Keh P. Diagnostic discrepancies in breast specimens subjected to gross reexamination. Am J Surg Pathol 1999, 23:876-879.
5. Olson D.R. Specimen photocopying for surgical pathology reports. Am J Clin Pathol 1978, 70:94-95.
6. Walsh S., Mirza T., Smith G., Hyde N. Impact of colour digital photography on pathologists' orientation of resected specimens: a prospective pilot study. Br J Oral Maxillofac Surg 2008, Epub.
7. Goldstein N.S., Soman A., Sacksner J. Disparate surgical margin lengths of colorectal resection specimens between in vivo and in vitro measurements. The effects of surgical resection and formalin fixation on organ shrinkage. Am J Clin Pathol 1999, 111:349-351.
8. Dirckx J.H. Chromatic fantasies. Color words in medicine. Am J Dermatopathol 1985, 7:157-161.
9. Bewtra C. Food in pathology. Am J Dermatopathol 1996, 18:555.
10. Wolff A.C., et al. American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer. Arch Pathol Lab Med 2007, 131:18-43.
11. Chung J.-Y., Braunschweig T., Williams R., et al. Factors in tissue handling and processing that impact RNA obtained from formalin-fixed, paraffin embedded tissue. J Histochem & Cytochem 2008, 56:1033-1042.
12. Hewitt S.M., Lewis F.A., Cao Y., et al. Tissue handling and specimen preparation in surgical pathology. Issues concerning the recovery of nucleic acids from formalin-fixed, paraffin-embedded tissue. Arch Pathol Lab Med 2008, 132:1929-1935.
13. National Cancer Institute Office of Biorepositories and Biospecimen Research ( ). http://biospecimens.cancer.gov.
14. Van Maldegem F., de Wit M., Morsink F., et al. Effects of processing delay, formalin fixation, and immunohistochemistry on RNA recovery from formalin-fixed paraffin-embedded tissue sections. Diagn Mol Pathol 2008, 17:51-58.
15. Loomis T.A. Formalin toxicity. Arch Pathol Lab Med 1979, 103:321-324.
16. Costa S., Coelho P., Costa C., et al. Genotoxic damage in pathology anatomy laboratory workers exposed to formaldehyde. Toxicology 2008, Epub.
17. Golden R., Pyatt D., Shields P.G. Formaldehyde as a potential human leukemogen: an assessment of biological plausibility. Crit Rev Toxicol 2006, 36:135-153.
18. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Volume 88: Formaldehyde, 2-Butoxyethanol and 1-tert-Butoxy-2-propanol, World Health Organization, Lyon, 2006.
19. Arber J.M., Arber D.A., Jenkins K.A., Battifora H. Effect of decalcification and fixation in paraffin-section immunohistochemistry. Appl Immunohistochem 1996, 4:241-248.
20. Dunn E., Nolte T. The potential toxicity of preserved gallstones [letter],. Vet Hum Toxicol 1994, 36:478.
21. Adegboyega P.A., Gokhale S. Effect of decalcification on the immunohistochemical expression of ABH blood group isoantigens. Appl Immunohistochem Mol Morphol 2003, 11:194-197.
22. Bateman A.C., Sage D.A., Al-Talib R.K. Investigation of specimen mislabelling in paraffin-embedded tissue using a rapid, allele-specific, PCR-based HLA class II typing method. Histopathol 1996, 28:169-174.
23. Hunt J.L. Identifying cross contaminants and specimen mix-ups in surgical pathology. Adv Anatomic Pathol 2008, 15:211-217.
24. Hunt J.L., Swalsky P., Sasatoni E., et al. A microdissection and molecular genotyping assay to confirm the identity of tissue floaters in paraffin-embedded tissue blocks. Am J Clin Pathol 2003, 127:213-217.
25. Ritter J.H., Sutton T.D., Wick M.R. Use of immunostains to ABH blood group antigens to resolve problems in identity of tissue specimens. Arch Pathol Lab Med 1994, 118:293-297.
26. Gephardt G.N., Zarbo R.J. Extraneous tissue in surgical pathology. A College of American Pathologists Q-Probes study of 275 laboratories. Arch Pathol Lab Med 1996, 120:1009-1014.
27. ADASP Standardization of the surgical pathology report. Am J Surg Pathol 1992, 16:84-86.
28. Zarbo R.J. Interinstitutional assessment of colorectal carcinoma surgical pathology report adequacy. Arch Pathol Lab Med 1992, 116:1113-1119.
29. Zarbo R.J., Gephardt G.N., Howanitz P.J. Intralaboratory timeliness of surgical pathology reports. Arch Pathol Lab Med 1996, 120:234-244.
30. Nakhleh R.E., Zarbo R.J. Amended reports in surgical pathology and implications for diagnostic error detection and avoidance. A College of American Pathologists Q-Probes Study of 1,667,547 accessioned cases in 359 laboratories. Arch Pathol Lab Med 1998, 122:303-309.
31. Meier F.A., Zarbo R.J., Varney R.C., et al. Amended reports: development and validation of a taxonomy of defects. Am J Clin Pathol 2008, 130:238-246.
32. ADASP critical diagnoses (critical values) in anatomic pathology. Am J Surg Pathol 2006, 30:897-899. Hum Pathol 37:982-984, 2006.
33. Consultations in surgical pathology Am J Surg Pathol 17:743-745, 1993 and Am J Clin Pathol 102:152-153. 1994 and Human Pathol 1993, 24:691-692.
34. Renshaw AA, Pinnar NE, Jiroutek MR, Young ML. Quantifying the value of in-house consultation in surgical pathology, Am J Clin Pathol 117:751-754.
35. Azam M., Nakhleh R.E. Surgical pathology extradepartmental consultation practices. A College of American Pathologists Q-probes study of 2746 consultations from 180 laboratories. Arch Pathol Lab Med 2002, 126:405-412.
36. Gupta D., Saul M., Gilbertson J. Evaluation of a deidentification (De-Id) software engine to share pathology reports and clinical documents for research. Am J Clin Pathol 2004, 121:169-171.
37. Rosen P.P. Special report: Perils, problems, and minimum requirements in shipping pathology slides. Am J Clin Pathol 1989, 91:348-354.
38. Intraoperative Consultations in Surgical Pathology. State of the Art Reviews 1996, Vol 3. Philadelphia Hanley & Belfus, No. 2. M. Ranchod (Ed.).
39. Volsi V.L. A surgical pathologist views practice parameters. Am J Clin Pathol 1995, 103:1-2.
40. Weiss S.W., et al. Frozen section consultation, utilization patterns and knowledge base of surgical faculty at a university hospital. Am J Clin Pathol 1995, 104:294-298.
41. Zarbo R.J., et al. Indications and immediate patient outcomes of pathology intraoperative consultations, a College of American Pathologists/Centers for Disease Control and Prevention Outcomes Working Group Study. Arch Pathol Lab Med 1996, 120:19-25.
42. Tuberculosis infection associated with tissue processing. MMWR 1981, 30:73-74.
43. Duray P.H., Flannery B., Brown S. Tuberculosis infection from preparation of frozen sections. NEJM 1981, 305:167.
44. Sidawy M.K., Silverberg S.G. Intraoperative cytology. Am J Clin Path 1991, 96:1-3.
45. Quality Improvement Manual in Anatomic Pathology, College of American Pathologists, 1993.
46. Sawady J., et al. Accuracy of and reasons for frozen sections: A correlative, retrospective study. Hum Pathol 1988, 19:1019-1023.
47. Association of Directors of Anatomic and Surgical Pathology, Recommendations on quality control and quality assurance in anatomic pathology. Hum Pathol 22:1099, 1991 or Am J Surg Pathol 15:1007-1009, 1991 or Mod Pathol 5:567-568, 1992.
48. Forrest L.A., Schuller D.E., Lucas J.G., Sullivan M.J. Rapid analysis of mandibular margins. Laryngoscope 1995, 105:475-477.
49. Abdul-Karim F.W., McGinnis M.G., Kraay M. et al. Frozen section biopsy assessment for the presence of polymorphonuclear leukocytes in patients undergoing revision of arthroplasties. Mod Pathol 1998, 11:427-431.
50. Bori G., Soriano A., Garcia S., et al. Usefulness of histological analysis for predicting the presence of microorganisms at the time of reimplantation after hip resection arthroplasty for the treatment of infection. J Bone Joint Surg Am 2007, 89:1232-1237.
51. Lonner J.H., et al. The reliability of analysis of intraoperative frozen sections for identifying active infection during revision hip or knee arthroplasty. J Bone Joint Surg Am 1996, 78:1553-1558.
52. Parvizi J., Ghanem E., Menashe S. et al. Periprosthetic infection: what are the diagnostic challenges?. J Bone Joint Surg Am 2006, 88:138-147.
53. Stamenkovic I., Lew D. Early recognition of potentially fatal ne crotizing fasciitis; the use of frozen-section biopsy. NEJM 310 1984, 1689-1693.
54. Majeski J., Majeski E. Necrotizing fasciitis: improved survival with early recognition by tissue biopsy and aggressive surgical treatment. South Med J 1997, 90:1065-1068.
55. Fechner R.E. Frozen section examination of breast biopsies, Practice parameter. Am J Clin Pathol 1995, 103:6-7.
56. Bianchi S., et al. Accuracy and reliability of frozen section diagnosis in a series of 672 nonpalpable breast lesions. Am J Clin Pathol 1995, 103:199-205.
57. Cox C.E., et al. Touch preparation cytology of breast lumpectomy margins with histologic correlation. Arch Surg 1991, 126:490-493.
58. England D.W., Chan S.Y., Stonelake P.S., Lee M.J.R. Assessment of excision margins following wide local excision for breast carcinoma using specimen scrape cytology and tumour bed biopsy. Eur J Surg Oncol 1994, 20:425-429.
59. Sauter E.R., et al. Is frozen section analysis of reexcision lumpectomy margins worthwhile? Margin analysis in breast reexcisions. Cancer 1994, 73:2607-2612.
60. Goldstein J.S., Soman A., Sacksner J. Disparate surgical margin lengths of colorectal resection specimens between in vivo and in vitro measurements. The effects of surgical resection and formalin fixation on organ shrinkage. Am J Clin Pathol 1999, 111:349-351.
61. McLeod R.S. Resection margins and recurrent Crohn's disease. Hepatogastroenterology 1990, 37:63-66.
62. Fazio V.W., Marchetti F., Church M. et al. Effect of resection margins on the recurrence of Crohn's disease in the small bowel. A randomized controlled trial. Ann Surg 1996, 224:563-571.
63. Hyland C., Kheir S.M., Kashlan M.B. Frozen section diagnosis of pancreatic carcinoma, a prospective study of 64 biopsies. Am J Surg Pathol 1981, 5:179-191.
64. Campanale R.P., Frey C.F., Farias R. et al. Reliability and sensitivity of frozen-section pancreatic biopsy. Arch Surg 1985, 120:283-288.
65. Tangjitgamol S., Jesadapatrakul S., Manusirivithaya S., Sheanakul C. Int J Gynecol Cancer 2004, 14:212-219.
66. Kir G., Kir M., Cetiner H. et al. Diagnostic problems on frozen section examination of myometrial invasion in patients with endometrial carcinoma with special emphasis on the pitfalls of deep adenomyosis with carcinomatous involvement. Eur J Gynaecol Oncol 2004, 25:211-214.
67. Spandorfer S.D., et al. Efficacy of frozen-section evaluation of uterine curettings in the diagnosis of ectopic pregnancy. Am J Obstet Gynecol 1996, 175:603.
68. Tschen J.A., Fechner R.E. The juxtaoral organ of Chievitz,. Am J Surg Pathol 1979, 3:147-150.
69. Gephardt G.N., Rice T.W. Utility of frozen-section evaluation of lymph nodes in the staging of bronchogenic carcinoma at mediastinoscopy and thoracotomy. J Thorac Cardiovasc Surg 1990, 100:853-859.
70. Gupta R., McKenna R., Marchevsky A.M. Lessons learned from mistakes and deferrals in the frozen section diagnosis of bronchioloalveolar carcinoma and well-differentiated pulmonary adenocarcinoma: an evidence-based pathology approach. Am J Clin Pathol 2008, 130:11-20.
71. Gupta R., Dastane A., Mckenna R.J., Marchevsky A.M. What can we learn from the errors in the frozen section diagnosis of pulmonary carcinoid tumors? An evidence-based approach. Human Pathol 2009, 40:1-9.
72. Evidence-based criteria to help distinguish metastatic breast cancer from primary lung adenocarcinoma on thoracic frozen section. Am J Clin Pathol 2009, 131:122-128.
73. Maygarden S.J., Detterbeck F.C., Funkhouser W.K. Bronchial margins in lung cancer resection specimens: utility of frozen section and gross evaluation. Mod Pathol 2004, May 7 (Epub).
74. Renshaw A.A. The relative sensitivity of special stains and cultures in open lung biopsies. Am J Clin Pathol 1994, 102:736-740.
75. Folkerth R.D. Smears and frozen sections in the intraoperative diagnosis of central nervous system lesions. Neurosurg Clin N Am 1994, 5:1-18.
76. Chen H., Nicol T.L., Udelsman R. Follicular lesions of the thyroid, Does frozen section evaluation alter operative management?. Ann of Surg 1995, 222:101-106.
77. Hamburger J.I., Hamburger S.W. Declining role of frozen section in surgical planning for thyroid nodules. Surgery 1985, 98:307-312.
78. Westra W.H., Pritchett D.D., Udelsman R. Intraoperative confirmation of parathyroid tissue during parathyroid exploration, a retrospective evaluation of the frozen section. Am J Surg Pathol 1998, 22:538-544.
79. Werner M., Chott Fabiano A., Battifora H. Effect of formalin fixation and processing on immunohistochemistry. Am J Surg Pathol 2000, 24:1016-1019.
80. Arber J.M., Arber D.A., Jenkins K.A., Battifora H. Effect of decalcification and fixation in paraffin-section immunohistochemistry. Applied Immunohistochem 1996, 4:241-248.
81. Fergenbaum J.H., Garcia-Closas M., Hewitt S.M., et al. Loss of antigenicity in stored sections of breast cancer tissue microarrays. Cancer Epidemiol Biomarkers Prev 2004, 13:667-672.
82. Wester K., Wahlund E., Sunderstrom C., et al. Paraffin section storage and immunohistochemistry: effects of time, temperature, fixation, and retrieval protocol with emphasis on p53 protein and MIB1 antigen. Appl Immunohistochem Mol Morphol 2000, 8:61-70.
83. Battifora H. Assessment of antigen damage in immunohistochemistry, the vimentin internal control. Am J Clin Pathol 1991, 6:669-671.
84. Chu P.G., Weiss L.M. Keratin expression in human tissues and neoplasms. Histopathology 2002, 40:403-439.
85. Gyure K.A., Morrison A.C. Cytokeratin 7 and 20 expression in choroid plexus tumors: utility in differentiating these neoplasms from metastatic carcinomas. Mod Pathol 2000, 13:638-643.
86. Wang N.P., Zee S., Zarbo R.J. Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas. Appl Immunohistochem 1995, 3:99-107.
87. Mierau G.W., Berry P.J., Malott R.L., et al. Appraisal of the comparative utility of immunohistochemistry and electron microscopy in the diagnosis of childhood round cell tumors. Ultrastruct Pathol 1996, 20:507-517.
88. Varadhachary G.R., Abbruzzese J.L., Lenzi R. Diagnostic strategies for unknown primary cancer. Cancer 2004, 100:1776-1785.
89. Harvey J.M., et al. J Clin Oncol 1999, 17:1474-1481.
90. Collins L.C., Botero M.L., Schnitt S.J. Bimodal frequency distribution of estrogen receptor immunohistochemical staining results in breast cancer: an analysis of 825 cases. Am J Clin Pathol 2005, 123:16-20.
91. Wolff A.C., et al. American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer. Arch Pathol Lab Med 2007, 131:18-43.
92. Battifora H. Metastatic breast carcinoma to the stomach simulating linitis plastica. Applied Immunohistochem 1994, 2:225-228.
93. O'Connell F.P., Wang H.H., Odze R.D. Utility of immunohistochemistry in distinguishing primary adenocarcinomas from metastatic breast carcinomas in the gastrointestinal tract. Arch Pathol Lab Med 2005, 129:338-347.
94. Corson J.M. Pathology of mesothelioma. Thorac Surg Clin N Am 2004, 14:447-460.
95. Kebbel A., Rocken C. Immunohistochemical classification of amyloid in surgical pathology revisited. Am J Surg Pathol 2006, 30:673-683.
96. Cao Y., Karsten U., Milqers J. Imnunohistochemical characterization of a panel of 56 antibodies with normal human small intestine, colon, and breast tissues. Tumor Biol 1998, 19(Suppl 1):88-99.
97. Electron Microscopy of Tumors, Seminars in Diagnostic Pathology, Volume 20: the entire February 2003 issue is devoted to electron microscopy.
98. Lerone DH. Medically Important Fungi, 4th edition: a guide to identification, ASM Press, 2004.
99. Chandler F.W., Watts J.C. Pathologic Diagnosis of Fungal Infections 1987, ASCP Press.
100. Nuovo G.J., Plaza J.A., Magro C. Rapid diagnosis of smallpox infection and differentiation from its mimics. Diag Mol Pathol 2003, 12:103-107.
101. Eyzaguirre E., Haque A.K. Application of immunohistochemistry to infections. Arch Pathol Lab Med 2008, 132:424-431.
102. McLaughlin-Drubin M.E., Munger K. Viruses associated with human cancer. Biochim Biophys Acta 2008, 1782:127-150.
103. Nuovo G.J. The utility of in situ-based methodologies including in situ polymerase chain reaction for the diagnosis and study of viral infections,. Hum Pathol 2007, 38:1123-1136.
104. Slifka M.K., Hanifin J.M. Smallpox: the basics. Dermatol Clin 2004, 22:263-274.
105. Montecalvo M.A., Lee M.S., DePalma H., et al. Seroprevalence of human immunodeficiency virus-1, hepatitis B virus, and hepatitis C virus in patients having major surgery. Inf Control Hosp Epidem 1995, 16:627-632.
106. Tuberculosis infection associated with tissue processing. MMWR 1981, 30:73-74.
107. Duray P.H., Flannery B., Brown S. Tuberculosis infection from preparation of frozen sections. NEJM 1981, 305:167.
108. CDC Hepatitis information line - 888-443-7243 ( ). http://www.cdc.gov/hepatitis.
109. Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis (June 29, 2001) - . http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5011a1.htm.
110. NIH consensus statement on management of Hepatitis C: 2002- . http://consensus.nih.gov.
111. Beltrami E.M., Cheingsong R., Heneine W.M., et al. Occupational HIV Exposure Study Group. Infect Control Hosp Epidemiol 2003, 24:724-730.
112. Current Public Health Service guidelines for post-exposure prophylaxis - . http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5011a1.htm.
113. Do A.N., Ciesielski C.A., Metler R.P., et al. Occupationally acquired human immunodeficiency virus (HIV) infection: national case surveillance data during 20 years of the HIV epidemic in the United States. Infect Control Hosp Epidemiol 2003, 24:86-96.
114. Johnson M.D., et al. Autopsy risk and acquisition of human immunodeficiency virus infection. Arch Pathol Lab Med 1997, 121:64-66. Johnson M, Working on a Miracle, Bantam, USA, 1998.
115. Gerberding J.L. Occupational exposure to HIV in health care settings. NEJM 2003, 348:826-833.
116. National Clinician's Post-Exposure Prophylaxis Hotline (PEPline), University of California, San Francisco - San Francisco General Hospital - 888-448-4911 ( ). http://www.ucsf.edu/hivcntr.
117. Needlestick! (an online decision-making support for clinicians), Emergency Medicine Center, UCLA School of Medicine - . http://www.needlestick.mednet.ucla.edu.
118. Nyberg M., et al. Isolation of human immunodeficiency virus (HIV) at autopsy one to six days postmortem. Am J Clin Pathol 1990, 94:422-425.
119. Paul S.M. Recommendations for reducing the risk of occupational HIV transmission, N J Med 2003, 100(9 Suppl):15-20.
120. Goette D.K., Jacobson K.W., Doty R.D. Primary inoculation tuberculosis of the skin. Prosector's paronychia. Arch Dermatol 1978, 114:567-569.
121. Templeton G.L., Illing L.A., Young L., et al. The risk for transmission of Mycobacterium tuberculosis at the bedside and during autopsy. Ann Int Med 1995, 122:922-925.
122. Gerston K.F., Blumberg L., Tshabalala V.A., et al. Viability of mycobacteria in formalin fixed lungs. Hum Pathol 2004, 35:571-575.
123. National Institute for Occupational Safety and Health - . http://www.cdc.gov/niosh/topics/SARS.
124. Brumbeck R.A. Routine use of phenolized formalin on autopsy brain tissue. N Engl J Med 1988, 319:654.
125. Brown P., Wolff A., Gajdusek D.C. A simple and effective method for inactivating virus activity in formalin-fixed tissue samples from patients with Creutzfeldt-Jakob disease. Neurology 1990, 40:887-890.
126. Burgess T.H., Steele K.E., Schoneboom B.A., Grieder F.B. Clinicopathologic features of viral agents of potential use by bioterrorists. Clin Lab Med 2001, 21:475-493.
127. Caya J.G., Agni R., Miller J.E. Clostridium botulinum and the clinical laboratorian. A detailed review of botulism, including biologic warfare ramifications of botulinum toxin. Arch Pathol Lab Med 2004, 128:653-662.
128. CDC Bioterrorism webpage: http://www.bt.cdc.gov.
129. Firmani M.A. Broussard, Molecular diagnostic techniques for use in response to bioterrorism. Expert Rev Mol Digan 2003, 3:605-615.
130. Guarner J., Jernigan J.A., Shieh W.J., et al. Pathology and pathogenesis of bioterrorism-related inhalational anthrax. Am J Pathol 2003, 163:701-709. and the Inhalation Anthrax Working Group.
131. Medical examiners, coroners, and biologic terrorism. A guidebook for surveillance and case management. Morbidity and Mortality Weekly Report, supplement 2004, vol. 53(No. RR-8).
132. Nelson A., Wilson M.L. Biothreat agents and pathology laboratories. Sem Diag Pathol 2007, 24:209-216.
133. Robinson-Dunn B. The microbiology laboratory's role in response to bioterrorism. Arch Pathol Lab Med 2002, 126:2910294.
134. Rollins S.E., Rollins S.M., Ryan E.T. Yersinia pestis and the plague. Am J Clin Pathol 2003, 119(Suppl):S78-S85.
135. Wun-Ju Shieh, Guarner J., Paddock C., et al. The critical role of pathology in the investigation of bioterrorism-related cutaneous anthrax. Am J Pathol 2003, 163:1901-1910. the Anthrax Bioterroism Investigation Team.
136. Loh E., Couch F.J., Hendricksen C., et al. Development of donor-derived prostate cancer in a recipient following orthotopic heart transplantation. JAMA 1997, 277:133-137.
137. Gärtner H.-V., Seidl C., Luckenbach C., et al. Genetic analysis of a sarcoma accidentally transplanted from a patient to a surgeon. N Eng J Med 1996, 335:1494-1496.
138. de Kanter A.Y., Arends P.P., Eggermont A.M., Wiggers T. Radiation protection for the sentinel node procedure in breast cancer. Eur J Surg Oncol 2003, 29:396-399.
139. Fitzgibbons P.L., LiVolsi V.A. Recommendations for handling radioactive specimens obtained by sentinel lymphadenectomy. Am J Surg Pathol 2000, 24:1549-1551. for the Surgical Committee of the College of American Pathologists and the Association of Directors of Anatomic Surgical Pathology.
140. Klausen T.L., Chakera A.H., Friis E., et al. Radiation doses to staff involved in sentinel node operations for breast cancer. Clin Physiol Funct Imaging 2005, 25:196-202. (Radiation levels to the hands of pathologists was below the detection limit in 17 cases.).
141. Law M., Chow L.W.C., Kwong A., Lam C.K. Sentinel lymph node technique for breast cancer: radiation safety issues. Sem Oncol 2004, 31:298-303.
142. Morton R., Horton P.W., Peet D.J., Kissin M.W. Quantitative assessment of the radiation hazards and risks in sentinel node procedures. Br J Radiol 2003, 76:117-122.
143. Stratmann S.L., McCarty T.M., Kuhn J.A. Radiation safety with breast sentinel node biopsy. Am J Surg 1999, 178:454-457.
144. Howie A.J., et al. Physical basis of colors seen in Congo red-stained amyloid in polarized light. Lab Inv 2008, 88:232.
145. Ro J.Y., et al. Yellow-brown (Hamazaki-Wesenberg) bodies mimicking fungal yeasts. Arch Pathol Lab Med 1987, 111:555-559.
146. Tuur S.M., et al. Liesegang rings in tissue. Am J Surg Pathol 1987, 11:598-605.
147. Keen C.E., Buk S.J.A., Brady K., Levison D.A. Fat necrosis presenting as obscure abdominal mass: Birefringent saponified fatty acid crystalloids as a clue to diagnosis. J Clin Pathol 1994, 47:1028-1031.
148. Kepes J.J., Yarde W.L. Visualization of injected embolic material (polyvinyl alcohol) in paraffin sections with Verhoeff-Van Gieson elastica stain. Am J Surg Pathol 1995, 19:709-711.
149. Al-Talib R.K., Wright D.H., Theaker J.M. Orange-red birefringence of gold particles in paraffin wax embedded sections: an aid to the diagnosis of chrysiasis. Histopathology 1994, 24:176-178.
150. Rashid A., Hamilton S.R. Necrosis of the gastrointestinal tract in uremic patients as a result of sodium polystyrene sulfonate (Kayexalate) in sorbitol. Am J Surg Pathol 1997, 21:60-69.
151. Donath K., LaaB M., Gunzl H- J. The histopathology of different foreign-body reactions in oral soft tissue and bone tissue. Virchows Archiv A Pathol Anat 1992, 420:131-137.
152. Fechner R.E., Nichols G.E. Iatrogenic lesions. Silverberg's Principles and Practice of Surgical Pathology and Cytopathology 2005, Churchill Livingstone. fourth edition. S.G. Silverberg, R.A. DeLellis, W.J. Frable (Eds.).
153. Forest M., Tomeno B., Vanel D. Pathology of bone and joints after surgery. In Orthopedic Surgical Pathology 1998, pp 739-759, Churchill Livingstone.
154. Johnson F.B. Crystals in pathologic specimens. Pathology Annual 1972, 321-348. Appleton-Century-Crofts, New York. S.C. Sommers (Ed.).
155. Walley V.M., Stinson W.A., Upton R.T., Santerre J.P., Mussivand T., Masters R.G., Ghadially F.N. Foreign materials found in the cardiovascular system after instrumentation or surgery (including a guide to their light microscopic identification). Cardiovasc Pathol 1993, 2:157-185.
156. Wallington E.A. Artifacts in tissue sections. Med Lab Sciences 1979, 36:3-61.
157. Yeh I.-T., Brooks J.S.J., Pietra G.G. Atlas of Microscopic Artifacts and Foreign Materials 1997, Williams & Wilkins, Baltimore.
158. Warren B.I., Davies J.D. Pierre Vernier's invention: a neglected tool of our trade. Histopathol 1991, 18:361-362.
159. Clark S.P., Kung I.T.M. Measurement of Breslow depth [letter]. J Pathol 1991, 165:269-270.
160. Calder C.J., Campbell A.P., Plastow S.R. Measurement techniques for melanoma: a statistical comparison. J Clin Pathol 1990, 43:922-923.
161. Uthman ED, An introduction to photography in general.. and gross specimen photography in particular ( ) . http://web2.airmail.net/uthman/gross_photo.html.
162. Walsh S., Mirza T., Smith G., Hyde N. Impact of colour digital photography on pathologists' orientation of resected specimens a prospective pilot study. Br J Oral Maxillofacial Surg 2008, (epub).
163. Stone M.J. The wisdom of Sir William Osler. Am J Cardiol 1995, 75:269-276.
164. Wolber R., Chercover D. Am J Surg Pathol 2003, 27:1020-1024. [letter to the editor].
165. Sirota R.L. The Institute of Medicine's Report on Medical Error. Arch Pathol Lab Med 2000, 124:1674-1678.
166. 2007 laboratory services national patient safety goals - and CAP laboratory patient safety plan - ). http://cap.org.
167. Cooper K. Errors and error rates in surgical pathology. An Association of Directors of Anatomic and Surgical Pathology Survey. Arch Pathol Lab Med 2006, 130:607-609.
168. Foucar E. Error in anatomic pathology. Am J Clin Pathol 2001, 116(Suppl):S34-S46.
169. Foucar E. Error identification, A surgical pathology dilemma. Am J Surg Pathol 1998, 22:1-5.
170. Foucar E. Do pathologists play dice? Uncertainty and early histopathological diagnosis of common malignancies. Histopathology 1997, 31:495-502.
171. Goldstein N.S. Diagnostic errors in surgical pathology. Clin Lab Med 1999, 19:743-756.
172. Hollensead S.C., Lockwood W.B., Elin R.J. Errors in pathology and laboratory medicine: consequences and prevention. J Surg Oncol 2004, 88:161-181.
173. Makary M.A., Epstein J., Pronovost P.J., et al. Surgical specimen identification errors: a newmeasure of quality in surgical care. Surgery 2007, 141:450-455.
174. Nakleh R.E. Patient safety and error reduction in surgical pathology. Arch Pathol Lab Med 2008, 132:181-185.
175. Raab S.S., Nakhleh R.E., Ruby S.G. Patient safety in anatomic pathology: measuring discrepancy frequencies and causes. Arch Pathol Lab Med 2005, 129:459-466.
176. Raab S.S., Grzybicki D.M. Measuring quality in anatomic pathology. Clin Lab Med 2008, 28:245-259.
177. Renshaw A.A. Measuring and reporting errors in surgical pathology. Lessons from gynecologic cytology. Am J Clin Pathol 2001, 115:338-341.
178. Troxel D.B. Error in surgical pathology. Am J Surg Pathol 2004, 28:1092-1095. There are also many other excellent articles by Dr. Troxel analyzing errors revealed by malpractice claims.
179. Nakhleh R.E., Zarbo R.J. Surgical pathology specimen identification and accessioning. A College of American Pathologists Q-Probes study of 1,004,115 cases from 417 institutions. Arch Pathol Lab Med 1996, 120:227-233.
180. Wiley E.L., Keh P. Diagnostic discrepancies in breast specimens subjected to gross reexamination. Am J Surg Pathol 1999, 23:876-879.
181. Powsner S.M., Costa J., Homer R.J. Clinicians are from Mars and pathologists are from Venus. Arch Pathol Lab Med 2000, 124:1040-1046.
182. Folkerth R.D. Smears and frozen sections in the intraoperative diagnosis of CNS lesions. Neurosurg Clin N Am 1994, 5:1-8. Contains tables of differential diagnosis of similar-appearing lesions.
183. Shimada H., Ambros I.M., Dehner L.P. Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee. Cancer 1999, 86:349-365.
184. Jarzembowski JA, et al: CAP Protocol for neuroblastoma at . http://www.cap.org.
185. Weiss L.M., Medeiros L.J., Vickery A.L. Pathologic features of prognostic significance in adrenal cortical carcinoma. Am J Surg Path 1989, 13:202-206.
186. Medeiros L.J., Weiss L.M. New developments in the pathologic diagnosis of adrenal cortical neoplasms. Am J Clin Pathol 1992, 97:73-83.
187. Aubert S., Wacreneir A., Leroy X., et al. Weiss system revisited. A clinicopathologic and immunohistochemical study of 49 adrenocortical tumors. AJSP 2002, 26:1612-1619.
188. Wieneke J.A., Thompson L.D.R., Heffess C.S. Adrenal cortical neoplasms in the pediatric population: A clinicopathologic and immunophenotype analysis of 83 patients. Am J Surg Pathol 2003, 27:867-881.
189. Medeiros L.J., Weiss L.M. Adrenal gland: Tumors and tumor-like lesions. The Difficult Diagnosis in Surgical Pathology, pgs 377-407 1996, WB Saunders, Philadelphia. N. Weidner (Ed.).
190. Kimura N., Watanabe T., Noshiro T. Histological grading of adrenal and extra-adrenal pheochromocytomas and relationship to prognosis: a clinicopathological analysis of 116 adrenal pheochromocytomas and 30 extra-adrenal sympathetic paragangliomas including 38 malignant tumors. Endocr Pathol 2005, 16:23-32.
191. Thompson L.D.R. Pheochromocytoma of the Adrenal Gland Scaled Score (PASS) to separate benign from malignant neoplasms. A clinicopathologic and immunophenotype study of 100 cases,. AJSP 2002, 26:551-566.
192. Henley D.J., van Heerden J.A., Grant C.S. Adrenal cortical carcinoma: a continuing challenge. Surgery 1983, 94:926-931.
193. Lack E. Tumors of the Adrenal Gland and Extra-Adrenal Paraganglia, AFIP Fascicle No. 19, Third Series 1997, American Registry of Pathology, Washington DC.
194. Shimada H., Ambros I.M., Dehner L.P., et al. The International Neuroblastoma Pathology Classification (the Shimada System),. Cancer 1999, 86:364-372.
195. Shimada H., Chatten J., Newton W.A., et al. Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomass. J Natl Cancer Inst 1984, 73:405-416.
196. Olson D.R. Specimen photocopying for surgical pathology reports. Am J Clin Pathol 1978, 70:94-95.
197. Barnes L., Johnson J.T. Pathologic and Clinical Consideration in the Evaluation of Major Head and Neck Specimens Resected for Cancer,. Path Ann (Part 1) 1986, 21:173-250. and Path Ann (Part 2), 21:83-110, 1986. (Head and neck.).
198. Weatherby R.P., Krishnan K.U. Practical aspects of handling orthopedic specimens in the surgical pathology laboratory, Path Annual, 17. part 1982, 2:1-31. (Bone resections with tumors.).
199. Patterson K. The pathologic handling of skeletal tumors. Am J Clin Pathol 1998, 109(Suppl 1):S53-S66.
200. Billings S.D., Wurtz L.D., Tejada E., Henley J.D. Occult sarcoma of the femoral head in patients undergoing total hip arthroplasty. J Bone Joint Surg 2000, 82-A:1536-1539.
201. Campbell M.L., Gregory A.M., Mauerhan D.R. Collection of surgical specimens in total joint arthroplasty. Is routine pathology cost effective?. J Arthroplasty 1997, 12:60.
202. Clark C.R., Bauer T. Routine pathological examination of operative specimens from primary total hip and total knee replacement: another look [Editorial]. J Bone Joint Surg 2000, 82-A:1529-1530.
203. DiCarlo E.F., Bullough P.G., Steiner G., et al. Pathological examination of the femoral head (FH). Mod Pathol 1994, 7(Abstract 16):6A.
204. Kocher M.S., Erens G., Thornhill T.S., Ready J.E. Cost and effectiveness of routine pathological examination of operative specimens obtained during primary total hip and knee replacement in patients with osteoarthritis. J Bone Joint Surg 1531-1535, 82-A.
205. Meding J.B., Ritter M.A., Jones N.L., et al. Determining the necessity for routine pathologic examinations in uncomplicated total hip and total knee arthroplasties. J Arthroplasty 2000, 15:69-71.
206. Palmer S.H., Gibbons C.L., Athanasou N.A. The pathology of bone allograft. J Bone Joint Surg Br 1999, 81:333-335.
207. JCAHO Standard QC.2.10, Comprehensive Accreditation Manual for Laboratory and Point-of-Care Testing, 2009.
208. Shidham V., Chivukula M., Basir Z., Shidham G. Evaluation of crystals in formalin-fixed, paraffin-embedded tissue sections for the differential diagnosis of pseudogout, gout, and tumoral calcinosis. Mod Pathol 2001, 14:806-810.
209. Yamakawa K., Iwasaki H., Masuda I., et al. The utility of alizarin red s staining in calcium pyrophosphate dihydrate crystal deposition disease. J Rheumatol 2003, 30:1032-1035.
210. th Series. Fascicle 2005, 2.
211. Weatherby R.P., Unni K.K. Practical aspects of handling orthopedic specimens in the surgical pathology laboratory, Path Ann, 17. part 1982, 2:1-31.
212. Patterson K. The pathologic handling of skeletal tumors. Am J Clin Pathol 1998, 109(Suppl 1):S53-S66.
213. Daftari T.K., Levine J., Fischgrund J.S., Herkowitz H.N. Is pathology examination of disc specimens necessary after routine anterior cervical discectomy and fusion?. Spine 1996, 21:2156.
214. Grzybicki D.M., Callaghan E.J., Raab S.S. Cost-benefit value of microscopic examination of intervertebral discs. J Neurosurg 1998, 89:378-381.
215. Hasselblatt M., Maintz D., Goll T., et al. Frequency of unexpected and important histopathological findings in routine intervertebral disc surgery. J Neurosurg Spine 2006, 4:20-23.
216. Reddy P., Williams R., Willis B., Nanda A. Pathological evaluation of intervertebral disc tissue specimens after routine cervical and lumbar decompression. A cost-benefit analysis retrospective study. Surg Neurol 2001, 56:252-255.
217. Wu A.S., Fourney D.R. Histopathological examination of intervertebral disc specimens: a cost-benefit analysis. Can J Neurol Sci. 2007, 34:451-455.
218. Moritz J.D., Luftner-Nagel S., Westerhof J.P., et al. Microcalcifications in breast core biopsy specimens: disappearance at radiography after storage in formaldehyde. Radiology 1996, 200:361-363.
219. Schnitt S.J., Wang H.H. Histologic sampling of grossly benign breast biopsies. How much is enough?. Am J Surg Path 1989, 13(6):505-512.
220. Carlson J.W., Birdwell R.L., Gombos E.C., et al. MRI-directed, wire-localized breast excisions: incidence of malignancy and recommendations for pathologic evaluation. Hum Pathol 2007, 38:1754-1759.
221. Owings D.V., Hann L., Schnitt S.J. How thoroughly should needle localization breast biopsies be sampled for microscopic examination: A prospective mammographic/pathologic correlative study. Am J Surg Pathol 1990, 14:578-583.
222. Abraham S.C., Fox K., Fraker D., et al. Sampling of grossly benign breast reexcisions. A multidisciplinary approach to assessing adequacy. Am J Surg Pathol 1999, 23:316-322.
223. Wiley E.L., Keh P. Diagnostic discrepancies in breast specimens subjected to gross reexamination. Am J Surg Pathol 1999, 23:876-879.
224. Andea A.A., Bouwman D., Wallis T., Visscher D.W. Correlation of tumor volume and surface area with lymph node status in patients with multifocal/multicentric breast carcinoma. Cancer 2004, 100:20-27.
225. th edition of the American Joint Committee on Cancer staging manual. Cancer 2003, 98:2740-2741.
226. Elston E., Ellis I.O. Grading invasive carcinoma. Breast Pathology 2006, New York, Churchill Livingstone. F.P. O'Malley, S.E. Pindar (Eds.).
227. Consensus conference on the classification of ductal carcinoma in situ the Consensus Conference Committee. Cancer 1997, 80:1798-1802.
228. Symmans W.F., Peintinger F., Hatzis C., et al. Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy. J Clin Oncol 2007, 25:4414-4422.
229. The World Health Organization: Tumours of the Breast and Female Genital Organs, pub. 2003.
230. Reinfuss M., Mitus J., Duda K., et al. The treatment and prognosis of patients with phyllodes tumor of the breast. An analysis of 170 cases. Cancer 1996, 77:910-916.
231. Nascimento A.F., Raut C.P., Fletcher C.D. Primary angiosarcoma of the breast: clinicopathologic analysis of 49 cases, suggesting that grade is not prognostic. Am J Surg Pathol 2008, 32:1896-1904.
232. Isern A.E., Loman N., Malina J., et al. Histopathologic findings and follow-up after prophylactic mastectomy and immediate breast reconstruction in 100 women from families with hereditary breast cancer. EJSO 2008, 34:1148-1154.
233. Khurana K.K., Loosmann A., Numann P.J., Khan S.A. Prophylactic mastectomy. Pathologic findings in high-risk patients. Arch Pathol Lab Med 2000, 124:378-381.
234. Leunen K., Drijkoningen M., Neven P., et al. Prophylactic mastectomy in familial breast carcinoma. What do the pathologic findings learn us?. Breast Cancer Res Treat 2008, 107:79-86.
235. Mequid M.M., Oler A., Numann P.J. Subareolar breast abscess: the penultimate stage of the mammary duct-associated inflammatory disease sequence. The Breast, Comprehensive Management of Benign and Malignant Diseases 1998, Saunders, p 109. second edition. K.I. Bland, E.M. Copeland (Eds.).
236. Cardiovascular Pathology 2001, Philadelphia, W.B. Saunders. 3 rd ed. M.D. Silver, A.I. Gotlieb, F.J. Schoen (Eds.).
237. Schoen F.J. Blood vessels, and The heart chapters. Robbins & Cotran Pathologic Basis of Disease 2009, 555-618. W.B. Saunders, Philadelphia, pp. 511-554. 8th ed. V. Kumar, A. Abbas, J. Aster, N. Fausto (Eds.).
238. Stewart S., Winters G.L., Fishbein M.C., et al. Revision of the 1990 Working Formulation for the Standardization of Nomenclature in the Diagnosis of Heart Rejection. J Heart Lung Transplantation 2005, 24:1710-1720.
239. Schoen F.J. Surgical pathology of removed natural and prosthetic cardiac valves. Hum Pathol 1987, 18:558.
240. Schoen F.J. Approach to the analysis of cardiac valve prostheses as surgical pathology or autopsy specimens. Cardiovasc Pathol 1995, 4:241-255.
241. Goldstein, et al. Implantable left ventricular assist devices. N Engl J Med 1998, 339:1522.
242. Hunt S.A., et al. Mechanical circulatory support and cardiac transplantation. Circulation 1998, 97:2079.
243. Schoen F.J., et al. Ventricular assist device (VAD) pathology analysis: Guidelines for clinical studies. J Appl Biomat 1990, 1:49.
244. Lewin K., et al. Softening techniques for nail biopsies. Arch Dermatol 1973, 107:223-224.
245. Shapiro L. Softening hard keratin in specimens for microscopic sections. Am J Clin Pathol 1970, 54:773-774.
246. Lee R.G., et al. Protocol for the examination of specimens removed from patients with esophageal carcinoma: A basis for checklists. Arch Pathol Lab Med 1997, 121:925-929.
247. Lewin K.J., Appelman H.D. Tumors of the Esophagus and Stomach. AFIP Fascicle 18, Third Series 1995, 293.
248. Fenger C. Histology of the anal canal. Am J Surg Pathol 1988, 12:41-55.
249. Am J Clin Pathol 1999, 111:349-351.
250. Thelmo W.L., Vetrano J.A., Wibowo A. Angiodysplasia of colon revisited: pathologic demonstration without the use of intravascular injection technique. Hum Pathol 1992, 23:37-40.
251. Mitsudo S.M., et al. Vascular ectasias of the right colon in the elderly: A distinct pathologic entity. Human Path 1979, 10:585.
252. Hytiroglou P., Thung S.N., Gerber M.A. Histological classification and quantitation of the severity of chronic hepatitis: keep it simple!. Seminars in Liver Disease 1995, 15:414-421.
253. Scheuer P.J. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 1991, 13:372-374.
254. Stocker J.T. An approach to handling pediatric liver tumors. Am J Clin Pathol 1998, 109(Suppl 1):S67-S72.
255. Cubilla A.L., et al. Lymph node involvement of the head of the pancreas area. Cancer 1978, 41:880-887.
256. Recommendations for reporting resected pancreatic neoplasms. Mod Pathol 1998, 11:500-504.
257. Racusen L.C., et al. The Banff 97 working classification of renal allograft pathology. Kid International 1999, 55:713-723.
258. Bijol V., Mendez G.P., Hurwitz S. et al. Evaluation of the nonneoplastic pathology in tumor nephrectomy specimens: predicting the risk of progressive renal failure. Am J Surg Pathol 2006, 30:575-584.
259. Henriksen K.J., Meehan S.M., Chang A. Non-neoplastic renal diseases are often unrecognized in adult tumor nephrectomy specimens: a review of 246 cases. Am J Surg Pathol 2007, 31:1703-1708.
260. Tickoo S.K., dePeralta-Venturina M.N., Harik L.R. et al. Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol 2006, 30:141-153.
261. Meng M.V., Koppie T.M., Duh Q.-Y., Stoller M.L. Novel method of assessing surgical margin status in laparoscopic specimens. Urology 2001, 58:677-682.
262. Meng M.V., Koppie T.M., Stoller M.L. Pathologic sampling of laparoscopically morcellated kidneys: a mathematical model. J Endourology 2003, 17:229-233.
263. Meng M.V., Miller T.R., Stoller M.L. Cytology of morcellated renal specimens: significance in diagnosis and dissemination. J Urol 2003, 169:45-48.
264. Qualman S.J., et al. Protocol for the examination of specimens from patients (children and young adults) with Wilms tumor (nephroblastoma) or other renal tumors of childhood. Arch Pathol Lab Med 2003, 127:1280-1289.
265. Zuppan C.W. Handling and evaluation of pediatric renal tumors. Am J Clin Pathol 1998, 109(Suppl 1):S31-S37.
266. Gephardt G.N., Baker P.B. Interinstitutional comparison of bladder carcinoma surgical pathology report adequacy, A College of American Pathologists Q-probes study of 7234 bladder biopsies and curettings in 268 institutions. Arch Pathol Lab Med 1995, 119:681-685.
267. rd series Fascicle 1994, Armed Forces Institute of Pathology, Washington, DC, p 199.
268. Renshaw A.A. Adequate tissue sampling of prostate core needle biopsies. Am J Clin Pathol 1997, 107:26-29.
269. Reyes A.O., Humphrey P.A. Diagnostic effect of complete histologic sampling of prostate needle biopsy specimens. Am J Clin Pathol 1998, 109:416-422.
270. Rubin M.A., Bismar T.A., Curtis S., Montie J.E. Prostate needle biopsy reporting. How are the surgical members of the Society of Urologic Oncology using pathology reports to guide treatment of prostate cancer patients?. Am J Surg Pathol 2004, 28:946-952.
271. Zigeuner R., Schips L., Lipsky K., et al. Detection of prostate cancer by TURP or open surgery in patients with previously negative transrectal prostate biopsies. Urology 2003, 62:883-887.
272. Murphy W.M., Dean P.J., Brasfield J.A., Tatum L. Incidental carcinoma of the prostate. How much sampling is adequate?. Am J Surg Pathol 1986, 10:170-174.
273. Moore G.H., Lawshe B., Murphy J. Diagnosis of adenocarcinoma in transureethral resectates of the prostate gland. Am J Surg Pathol 1986, 10:165-169.
274. Newman A.J., Graham M.A., Carlton C.E., et al. Incidental carcinoma of the prostate at the time of transurethral resection: Importance of evaluating every chip. J Urol 1982, 128:948-950.
275. Geddy P.M., Reid I.N. Selective sampling of yellow prostate chips: a specific method for detecting prostatic adenocarcinoma. Urol Int 1996, 56:33-35.
276. Humphrey P.A., Walther P.J. Adenocarcinoma of the prostate. I. Tissue sampling considerations. Am J Clin Pathol 1993, 99:746-759.
277. Bova G.S., Fox W.M., Epstein J.I. Methods of radical prostatectomy specimen processing: A novel technique for harvesting fresh prostate cancer tissue and review of processing techniques. Mod Pathol 1993, 6:201-207.
278. Humphrey P.A., Vollmer R.T. Percentage carcinoma as a measure of prostatic tumor size in radical prostatectomy tissues. Mod Pathol 1997, 10:326-333.
279. Renshaw A.A., Chang H., D'Amico A.V. Estimation of tumor volume in radical prostatectomy specimen in routine clinical practice. Am J Clin Pathol 1997, 107:704-708.
280. Renshaw A.A., Richie J.P., Loughlin K.R. et al. The greatest dimension of prostate carcinoma is a simple, inexpensive predictor of prostate specific antigen failure in radical prostatectomy specimens. Cancer 1998, 83:748-752.
281. Epstein J.I., Allsbrook W.C., Amin M.B., Egevad L.L. ISUP Grading Committee. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol 2005, 29:1228-1242.
282. Gleason D.F. Histologic grading of prostate cancer: A perspective. Hum Pathol 1992, 23:273-279.
283. Hawkins E.P. Germ cell tumors. Am J Clin Pathol 1998, 109(Suppl 1):S82-S88.
284. Warde P., et al. Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis. J Clin Oncol 2002, 20:4448-4452.
285. Surgical Specimens to Be Submitted to Pathology for Examination, revised November 2007, CAP Reference Resources and Publications, CAP Public Policy Compendium, . http://www.cap.org.
286. Zarbo R.J., Nakhleh R.E. Surgical pathology specimens for gross examination only and exempt from submission. A College of American Pathologists Q-Probes study of current policies in 413 institutions. Arch Pathol Lab Med 1999, 123:133-139.
287. Raab S.S. The cost-effectiveness of routine histologic examination. Am J Clin Pathol 1998, 110:391-396.
288. Kurman R.J., Norris H.J. Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma. Cancer 1982, 49:2547-2559.
289. Roberts D.J., et al. Placental pathology, a survival guide. Arch Path Lab Med 2008, 132(4):641-651.
290. Bajoria R., Wigglesworth J., Fisk N.M. Angioarchitecture of monochorionic placentas in relation to the twin-twin transfusion syndrome. Am J Obstet Gynecol 1995, 172:856-863.
291. de Carpentier J.P., et al. An algorithmic approach to aspergillus sinusitis. J Laryngol Otol 1994, 108:314-318.
292. Hartwick R.W., Batsakis J.G. Sinus aspergillosis and allergic fungal sinusitis. Ann Otol Rhinol Laryngol 1991, 100:427-430.
293. Panda N.K., Balaji P., Chakrabarti A. Paranasal sinus aspergillosis: its categorization to develop a treatment protocol. Mycoses 2004, 47:277-283.
294. Waxman J.E., Spector J.G., Sale S.R., Katzenstein A.L. Allergic Aspergillus sinusitis: concepts in diagnosis and treatment of a new clinical entity. Laryngoscope 1987, 97(3 Pt 1):261-266.
295. Robbins K.T., Shaha A.R., Medina J.E., et al. Consensus statement on the classification and terminology of neck dissection. Arch Otolaryngol Head Neck Surg 2008, 134:536-538.
296. Daniels T.E., Whitcher J.P. Association of patterns of labial salivary gland inflammation with keratoconjunctivitis sicca. Analysis of 618 patients with suspected Sjögren's syndrome. Arthritis Rheum 1994, 37:869-877.
297. Netser J.C., et al. Value-based pathology; a cost-benefit analysis of the examination of routine and nonroutine tonsil and adenoid specimens. Am J Clin Pathol 1997, 108:158-165.
298. El-Mofty S.K., Lu D.W. Prevalence of Human Papillomavirus Type 16 DNA in squamous cell carcinoma of the palatine tonsil, and not the oral cavity, in young patients: a distinct clinicopathologic and molecular disease entity. Am J Surg Pathol 2004, 27:1463-1470.
299. Montgomery E., Buras R. Incidental liposarcomas indentified during hernia repair operations. J Surg Oncol 1999, 71:50-53.
300. Gomez-Ramon J.J., Mayorga M., Mira C., et al. Glandular inclusions in inguinal hernia sacs: a clinicopathologic study of six cases. Pediatr Pathol 1994, 14:1043-1049.
301. Popek E.J. Embryonal remnants in inguinal hernia sacs. Hum Pathol 1990, 21:339-349.
302. Steigman C.K., Sotelo-Avila C., Weber T.R. The incidence of spermatic cord structures in inguinal hernia sacs from male children,. Am J Surg Pathol 1999, 23:880-885.
303. Walker A.N., Mills S.E. Glandular inclusions in inguinal hernia sacs and spermatic cords. Am J Clin Pathol 1984, 82:85-89.
304. Stewart S., Fishbein M.C., Snell G.I., et al. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant 2007, 26:1229-1242.
305. Bianchi C., Brollo A., Ramani L., Zuch C. Pleural plaques as risk indicators for malignant pleural mesothelioma: a necroscopy-based study. Am J Industrial Med 1997, 32:445-449.
306. MacLennan K.A., Bennett M.H., Tu A., et al. Relationship of histopathologic features to survival in nodular sclerosing Hodgkin's disease. Cancer 1989, 64:1686-1693.
307. Billmoria K.Y., Bentrem D.J., Stewart A.K. Lymph node evaluation as a colon cancer quality measure: a national hospital report card. J Natl Cancer Inst 2008, 100:1310-1317.
308. Govindarajan A., Baxter N.N. Lymph node evaluation in early-stage colon cancer. Clin Colorectal Cancer 2008, 7:240-246.
309. Johnson P.M., Porter G.A., Ricciardi R., Baxter N.N. Increasing negative lymph node count is independently associated with improved long-term survival in Stage IIIB and IIIC colon cancer. J Clin Oncol 2006, 24:3570-3575.
310. Simunovic M., Baxter N.N. Lymph node counts in colon cancer surgery. Lessons for users of quality indicators [Editorial]. JAMA 2007, 298:2194-2195.
311. Washington M.K. Colorectal carcinoma: selected issues in pathologic examination and staging and determination of prognostic factors. Arch Pathol Lab Med 2008, 132:1600-1607.
312. Wong S.L., Hong J., Hollenbeck B.K. Hospital lymph node examination rates and survival after resection for colon cancer. JAMA 2007, 298:2149-2154.
313. Koren R., Kyzer S., Paz A. Lymph node revealing solution: A new method for detection of minute axillary lymph nodes in breast cancer specimens. Am J Surg Pathol 1997, 21:1387-1390.
314. Association of Directors of Anatomic and Surgical Pathology (ADASP) recommendations for processing and reporting of lymph node specimens submitted for evaluation of metastastic disease. Mod Pathol 2001, 14:629-632.
315. Brennick J.B., Yan S. False-positive cells in sentinel lymph nodes. Semin Diagn Pathol 2008, 25:116-119.
316. Fitzgibbons P.L., Page D.L., Weaver D. Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000, 124:966-978.
317. Gould V.E., Bloom K.J., Franke W.W., et al. Increased numbers of cytokeratin-positive interstitial reticulum cells (CIRC) in reactive, inflammatory and neoplastic lymphadenopathies: Hyperplasia or induced expression?. Virchows Arch 1995, 425:617-630.
318. Scolyer R.A., Murali R., McCarthy S.W., Thompson J.F. Pathologic examination of sentinel lymph nodes from melanoma patients. Semin Diagn Pathol 2008, 25:100-111.
319. Smith P.A.F., Harlow S.P., Krag D.N., Weaver D.L. Submission of lymph node tissue for ancillary studies decreases the accuracy of conventional breast cancer axillary node staging. Mod Pathol 1999, 12:781-785.
320. Weaver D.L. Sentinel lymph nodes and breast carcinoma: which micrometastases are clinically significant?. Am J Surg Pathol 2003, 27:842-845.
321. Xu S., Roberts S.A., Pasha T.L., Zhang P.J. Undesirable cytokeratin immunoreactivity of native nonepithelial cells in sentinel lymph nodes from patients with breast carcinoma. Arch Pathol Lab Med 2000, 124:1310-1313.
322. Zhang P.J., Reisner R.M., Nangia R. Effectiveness of multiple-level sectioning in detecting axillary nodal micrometastasis in breast cancer: a retrospective study with immunohistochemical analysis. Arch Pathol Lab Med 1998, 122:687-690.
323. Fitzgibbons PL, LiVolsi VA, for the Surgical Committee of the College of American Pathologists and the Association of Directors of Anatomic Surgical Pathology, Recommendations for handling radioactive specimens obtained by sentinel lymphadenectomy, Am J Surg Pathol 24:1549-1551, 2000.
324. Law M., Chow L.W.C., Kwong A., Lam C.K. Sentinel lymph node technique for breast cancer: radiation safety issues. Seminars in Oncology 2004, 31:298-303.
325. Morton R., Horton P.W., Peet D.J., Kissin M.W. Quantitative assessment of the radiation hazards and risks in sentinel node procedures. Br J Radiol 2003, 76:117-122.
326. Stratmann S.L., McCarty T.M., Kuhn J.A. Radiation safety with breast sentinel node biopsy. Am J Surg 1999, 178:454-457.
327. Brown A simple and effective method for inactivating virus infectivity in formalin-fixed tissue samples from patients with Creutzfeldt-Jakob disease. Neurology 1990, 40:887-890.
328. Budka H., Aguzzi A., Brown P., et al. Tissue handling in suspected Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol 1995, 5:319-322.
329. Fichet G., Comoy E., Duval C., et al. Novel methods for disinfection of prion-contaminated medical devices. Lancet 2004, 364:521-526.
330. Cavenee W.K., Louis D.N., Ohgaki H. Wiestler. WHO Classification of Tumours of the Central Nervous System 2007, IARC Press, Lyon.
331. Montgomery E., Buras R. Incidental liposarcomas indentified during hernia repair operations. J Surg Oncol 1999, 71:50-53.
332. Qualman S.J., et al. Protocol for the Examination of Specimens from patients (children and young adults) with rhabdomyosarcoma. Arch Pathol Lab Med 2003, 127:1290-1297.
333. Trojani M., Contesso G., Coindre J.-M., et al. Soft-tissue sarcomas of adults: study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer 1984, 33:37-42.
334. Guillou L., Coindre J.M., Bonichon F., et al. A comparative study of the NCI and FNCLCC grading systems in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol 1997, 15:350-362.
335. Guillou L., Coindre J.-M. How should we grade soft tissue sarcomas and what are the limitations?. Pathology Case Reviews 1998, 3:105-110.
336. Goh B.K., Chow P.K., Yap W.M. Which is the optimal risk stratification system for surgically treated localized primary GIST? Comparison of three contemporary prognostic criteria in 171 tumors and a proposal for a modified Armed Forces Institute of Pathology risk criteria. Ann Surg Oncol.15 2008, 2153-2163.
337. Huang H.-Y., Li C.-F., Huang W.-W., et al. A modification of NIH consensus criteria to better distinguish the highly lethal subset of primary localized gastrointestinal stromal tumors: a subdivision of the original high-risk group on the basis of outcome. Surgery 2007, 141:748-756.
338. Wick M.R. Prognostic factors for thymic epithelial neoplasms, with emphasis on tumor staging. Hematol Oncol Clin North Am 2008, 22:527-542.